TC BioPharm (TCBP)

Company Profile

TC BioPharm (Holdings) plc (TCB) is a clinical-stage biopharmaceutical company with a cell-based product pipeline capable of treating a variety of disorders including cancer and infectious disease.

Company profile

Ticker

TCBP, TCBPW

Exchange

Incorporated

Location

Fiscal year end

Sector

Professional, Scientific, and Technical Services > Research and Development in Biotechnology

Industry (SIC)

Biological Products, (No Diagnostic Substances)

AMGEN • Gilead Sciences • Biogen • Qiagen • Moderna • BioNTech SE • Bio-Techne • Sana Biotechnology • Ginkgo Bioworks • Acorda Therapeutics ...

Former names

TC BioPharm (Holdings) Ltd

SEC CIK

0001872812

Corporate docs

Underwriting Agreements

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

TCBP stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

424B3

Prospectus supplement

8 Nov 23

EFFECT

Notice of effectiveness

7 Nov 23

F-3/A

Shelf registration (foreign) (amended)

2 Nov 23

6-K

Current report (foreign)

2 Nov 23

CORRESP

Correspondence with SEC

Shelf registration (foreign)

29 Sep 23

424B3

Prospectus supplement

1 Sep 23

424B3

Prospectus supplement

1 Sep 23

6-K

Current report (foreign)

31 Aug 23

Latest ownership filings

View all

ARMISTICE CAPITAL, LLC

Diana Elizabeth Randall

Kenneth Edward Randall

11 Jan 23

Mark Edward Randall

11 Jan 23

Kenneth Edward Randall

11 Jan 23

SC 13D/A

Renaissance Capital Partners Ltd

11 Jan 23

Change in insider ownership

11 Jan 23

Financial summary

Financial statements Chart TCBP financial data

Quarter (USD)	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q3 2023

TCBP institutional ownership history Ownership history

40.8% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	15	11	+36.4%
Opened positions	8	4	+100.0%
Closed positions	4	1	+300.0%
Increased positions	0	2	EXIT
Reduced positions	4	0	NEW

13F shares	Current	Prev Q	Change
Total value	648.10 mm	348.81 mm	+85.8%
Total shares	3.82 mm	4.84 mm	-21.1%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Alta Partners	2.93 mm	$6.20 mm	0.0%
Renaissance Capital Partners	382.96 k	$1.80 mm	0.0%
Armistice Capital	297.50 k	$127.93 mm	-47.4%
MEDINET	73.50 k	$0.00	0.0%
Csenge Advisory	26.00 k	$11.18 mm	NEW
Cresset Asset Management	25.00 k	$10.75 mm	NEW
Modera Wealth Management	16.24 k	$466.03 mm	NEW
XTX Topco	13.62 k	$5.69 mm	NEW
Citadel Advisors	13.54 k	$5.65 mm	-82.0%
Two Sigma Securities	13.40 k	$5.76 mm	NEW

Largest transactions	Shares	Bought/sold	Change
Kepos Capital	0.00	-470.59 k	EXIT
Armistice Capital	297.50 k	-268.46 k	-47.4%
Nantahala Capital Management	0.00	-235.29 k	EXIT
Citadel Advisors	13.54 k	-61.75 k	-82.0%
Renaissance Technologies	11.00 k	-60.90 k	-84.7%
Csenge Advisory	26.00 k	+26.00 k	NEW
Cresset Asset Management	25.00 k	+25.00 k	NEW
Altium Capital Management	0.00	-18.82 k	EXIT
Modera Wealth Management	16.24 k	+16.24 k	NEW
XTX Topco	13.62 k	+13.62 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

TCBP insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
30 Nov 22	Renaissance Capital Partners	Ordinary Shares [ADS]	Buy	Acquire P	No	No	5	70,000	350.00 k	136,834
30 Nov 22	Renaissance Capital Partners	Series B Warrants Ordinary Shares	Buy	Acquire P	No	No	5	70,000	350.00 k	70,000
30 Nov 22	Renaissance Capital Partners	Series A Warrants Ordinary Shares	Buy	Acquire P	No	No	5	70,000	350.00 k	70,000
30 Nov 22	Kenneth Edward Randall	Ordinary Shares [ADS]	Buy	Acquire P	Yes	No	5	70,000	350.00 k	382,963
30 Nov 22	Kenneth Edward Randall	Series B Warrants Ordinary Shares	Buy	Acquire P	Yes	No	5	70,000	350.00 k	70,000
30 Nov 22	Kenneth Edward Randall	Series A Warrants Ordinary Shares	Buy	Acquire P	Yes	No	5	70,000	350.00 k	70,000
30 Nov 22	Mark Edward Randall	Ordinary Shares [ADS]	Buy	Acquire P	Yes	No	5	70,000	350.00 k	382,963
30 Nov 22	Mark Edward Randall	Series B Warrants Ordinary Shares	Buy	Acquire P	Yes	No	5	70,000	350.00 k	70,000
30 Nov 22	Mark Edward Randall	Series A Warrants Ordinary Shares	Buy	Acquire P	Yes	No	5	70,000	350.00 k	70,000
30 Nov 22	Kenneth Edward Randall	Ordinary Shares [ADS]	Buy	Acquire P	Yes	No	5	70,000	350.00 k	136,834